Lemaitre Vascular (LMAT) Payables (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Payables data on file, last reported at $4.2 million in Q1 2026.

• On a quarterly basis, Payables rose 91.66% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was $4.2 million, a 91.66% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 107.04% from the prior year.
• Payables for Q1 2026 stood at $4.2 million, up from $3.6 million in the prior quarter.
• Over the last five years, Payables for LMAT reached as high as $4.9 million in Q2 2025 and fell as low as $1.7 million in Q3 2024.
• Historically, Payables has averaged $3.1 million across 5 years, with a median of $3.1 million in 2024.
• Across the five-year window, Payables plunged 62.23% in 2024 and soared 146.32% in 2025, its largest moves.
• Year by year, Payables stood at $2.9 million in 2022, then advanced by 28.63% to $3.7 million in 2023, then sank by 52.84% to $1.8 million in 2024, then jumped by 107.04% to $3.6 million in 2025, then climbed by 14.65% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $4.2 million in Q1 2026, $3.6 million in Q4 2025, and $3.5 million in Q3 2025.